AAPG - Ascentage Pharma Group International Company Long-Term Liabilities

Public company logo of Ascentage Pharma Group International (AAPG)

The development of molecules to trigger apoptosis in resistant tumors is driving the dynamics of Ascentage Pharma Group (AAPG) long-term liabilities. The business relies on inhibitor patents to create targeted drugs. Its status as a rising star in Chinese oncology strengthens the brand image. The current value of 0.05 determines the status of the debt capital parameter raised to expand the company's production capacities.

ascentage.com (AAPG) Company Long-Term Debt: for the period 01/25/2025 - 10/29/2026

Ascentage (AAPG) - metric breakdowns and financial figures

- share price and expert price forecast:
Share Price ascentage.com|AAPG - Analyst Consensus Forecast
- market capitalization statistics:
Market Valuation Ascentage Pharma|AAPG - Enterprise Value
- shareholders' equity book value data:
Net Asset Value per Share Ascentage Pharma|AAPG - Company Book Value|Market Value to Book Value ascentage.com|AAPG - Cumulative Company Assets
- business debt structure and liquidity details:
All Debt to Shareholders' Equity Ratio Ascentage Pharma Group|AAPG - Long-Term Debt to Capital|Short-Term Debt to Equity Ratio Ascentage Pharma Corp|AAPG - Company Total Debt|Debts to Book Capitalization Ascentage Pharma|AAPG - Company Long-Term Debt|Company Short-Term Loans and Borrowings Ascentage Pharma
Fundamental company valuation:AAPG (ascentage.com)
Brand item of Ascentage Pharma Group

Long-term debt reflects the aggregate of credit obligations with a maturity horizon exceeding one year, allowing for an assessment of capital structure stability and the level of financial leverage. By analyzing the long-term borrowed capital of Ascentage Pharma Group (AAPG) on GURU.Markets, an investor can distinguish the strategic financing of Ascentage Pharma Group (AAPG) R&D projects for the creation of targeted antitumor drugs from a critical debt load that determines the development potential of this biopharmaceutical innovator.

Competitors of Ascentage Pharma Group (AAPG)

ONC: Company Long-Term Indebtedness|Halozyme - Company Long-Term Debts|Revolution Medicines Inc (RVMD) - Company Long-Term Liabilities|CGON: Company Long-Term Debts|Long-Term Debt UroGen Pharma Corp (URGN)|Company Long-Term Debt Bicara Therapeutics Inc.|PSNL: Company Long-Term Loans and Borrowings|Company Long-Term Liabilities ERAS (Erasca)|DCTH (Delcath Systems Inc) - Company Long-Term Loans and Borrowings|Company Long-Term Debts YMAB (YmAbs)|AURA - Company Long-Term Liabilities|CADL: Company Long-Term Liabilities|ARAY - Company Long-Term Debts|sellaslifesciences.com (SLS) - Company Long-Term Debt|Actuate Therapeutics Inc. - Company Long-Term Loans and Borrowings|CTOR (Citius Oncology, Inc) - Company Long-Term Debts|Long-Term Debt TuHURA HURA|Company Long-Term Debts TARA|Company Long-Term Debts fatetherapeutics.com (FATE)|Company Long-Term Debt Aadi Bioscience WHWK|Long-Term Debt Volume TScan Therapeutics Inc (TCRX)|Champions Oncology Corp - Company Long-Term Debts|XBiotech Inc. (XBIT) - Company Long-Term Liabilities|CVM: Company Long-Term Debts|Long-Term Debt ostherapies.com (OSTX)|Company Long-Term Debt Radiopharm Theranostics Limited|Company Long-Term Indebtedness ARTV (Artiva)|Company Long-Term Liabilities ANL (Adlai Nortye Ltd.)|Amount of Long-Term Liabilities VERU|Company Long-Term Debts TPST (Tempest Therapeutics)|Company Long-Term Debts Xilio Therapeutics Inc XLO|Enochian BioSciences - Company Long-Term Debts|Long-Term Indebtedness Mural Oncology plc (MURA)|KAPA: Company Long-Term Debts|Long-Term Debt OnKure Therapeutics (OKUR)|Company Long-Term Liabilities GDTC|CRIS: Company Long-Term Loans and Borrowings|Company Long-Term Debt Apollomics, Inc. (APLM)|THAR: Long-Term Liabilities|Company Long-Term Debts ADVB (Advanced Biomed)|Company Long-Term Loans and Borrowings GNPX|Calidi Bio - Company Long-Term Debts|SBFM - Company Long-Term Debts|xeneticbio.com (XBIO) - Company Long-Term Debt|Salarius Pharmaceuticals Inc - Company Long-Term Loans and Borrowings|Company Long-Term Debt Purple Biotech Corp|Company Long-Term Liabilities AON (AONC)|Company Long-Term Debts BGNE|Company Long-Term Debts checkpointtx.com (CKPT)|Elevation Oncology, Inc. - Company Long-Term Liabilities|Company Long-Term Loans and Borrowings ICAD|Ikena - Company Long-Term Debts|Long-Term Indebtedness Notable Labs Corp (NTBL)|viracta.com (VIRX) - Company Long-Term Debt|morphosys.com - Company Long-Term Loans and Borrowings|Company Long-Term Debt NAYA Biosciences Inc.|Long-Term Debt Ascentage Pharma Group International AAPGV